Cargando…
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117596/ https://www.ncbi.nlm.nih.gov/pubmed/32212881 http://dx.doi.org/10.2217/imt-2020-0067 |
| _version_ | 1783514403648307200 |
|---|---|
| author | Bersanelli, Melissa |
| author_facet | Bersanelli, Melissa |
| author_sort | Bersanelli, Melissa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7117596 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71175962020-04-02 Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors Bersanelli, Melissa Immunotherapy Commentary Future Medicine Ltd 2020-03-26 2020-03 /pmc/articles/PMC7117596/ /pubmed/32212881 http://dx.doi.org/10.2217/imt-2020-0067 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Commentary Bersanelli, Melissa Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
| title | Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
| title_full | Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
| title_fullStr | Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
| title_full_unstemmed | Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
| title_short | Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
| title_sort | controversies about covid-19 and anticancer treatment with immune checkpoint inhibitors |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117596/ https://www.ncbi.nlm.nih.gov/pubmed/32212881 http://dx.doi.org/10.2217/imt-2020-0067 |
| work_keys_str_mv | AT bersanellimelissa controversiesaboutcovid19andanticancertreatmentwithimmunecheckpointinhibitors |